
Halozyme sues Merck; FDA blames cuts for Vanda delay
Today, a brief rundown of news involving Merck and Vanda Pharmaceuticals, as well as updates from Sanofi and Novo Holdings that you may have missed. Halozyme Therapeutics has sued Merck & Co., alleging that the pharmaceutical company is infringing on …